Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment.
about
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applicationsAn anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loopSingle domain antibodies: promising experimental and therapeutic tools in infection and immunityVHH antibodies: emerging reagents for the analysis of environmental chemicalsMethod for Sorting and Pairwise Selection of Nanobodies for the Development of Highly Sensitive Sandwich ImmunoassaysIsolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassayThe role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodiesNanobody: the "magic bullet" for molecular imaging?Fluorescent labelling of the actin cytoskeleton in plants using a cameloid antibody.Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library.Heating as a rapid purification method for recovering correctly-folded thermotolerant VH and VHH domains.Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complexCompetitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune responseIsolation of a highly thermal stable lama single domain antibody specific for Staphylococcus aureus enterotoxin B.Heat-induced irreversible denaturation of the camelid single domain VHH antibody is governed by chemical modifications.Development and utilization of camelid VHH antibodies from alpaca for 2,2',4,4'-tetrabrominated diphenyl ether detection.Expression cloning of camelid nanobodies specific for Xenopus embryonic antigensIn vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).Evaluation of antidiphtheria toxin nanobodies.Recombinant expression and purification of human placental growth factor 1 and specific camel heavy chain polyclonal antibody preparation.Nanobodies®: proficient tools in diagnostics.Nanobody; an old concept and new vehicle for immunotargeting.Biotechnological applications of recombinant single-domain antibody fragments.Recombinant antibodies and their use in biosensors.A toxin-free enzyme-linked immunosorbent assay for the analysis of aflatoxins based on a VHH surrogate standard.Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.Stabilization of an immunoglobulin fold domain by an engineered disulfide bond at the buried hydrophobic region.Single Domain Antibodies as New Biomarker Detectors.Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook.Heat denaturation of the antibody, a multi-domain protein.VHH Antibodies: Reagents for Mycotoxin Detection in Food Products.Sensitive detection of Bacillus thuringiensis Cry1B toxin based on camel single-domain antibodies.A nanobody-based electrochemiluminescent immunosensor for sensitive detection of human procalcitonin.Nanobody Technology for Mycotoxin Detection in the Field of Food Safety: Current Status and Prospects.Caffeine-inducible gene switches controlling experimental diabetes.
P2860
Q26738678-E30B5448-18D6-4F0E-8B5B-9E2CB18DFDA8Q27667776-B7AD8DFB-D0E1-429A-8BF4-8B13CE2DAB8EQ28248678-CF95CB00-E83E-4F6F-9497-B627FF2AA329Q28386514-81323B0D-41C5-4D89-B9B1-39CACBF47D5DQ28395341-59C7F6D5-C7C5-4CF7-886E-F7B3707BD814Q28395939-2204E841-96E4-418A-826E-5D72CD48BC11Q28833254-1575EC08-4F05-4AD7-BD83-96F25E543DD0Q30442626-AA19DF31-9EC9-4E11-8846-F1A7839759D3Q30579087-951376B2-F37B-4054-A5A6-F88CBD46D078Q33266393-53B121BC-CE14-4442-8B1D-B748167DBDA0Q33270541-4B6C92E8-7F0A-418E-8F49-A69C0617D1E5Q33378940-F12938E7-F81F-4A3D-98B8-DF59CCB88245Q33986454-169FD3FA-8367-4913-AD06-FAEE3A179343Q34024718-2DF948F8-D2D2-4951-9594-AC2BFED48AD0Q34076016-4ADE1817-A0AE-4D5E-8B97-1CCD89D65649Q34089104-2CB339BF-1C3A-4DCF-9A11-C98F287B6E11Q34294085-F64A31E5-2007-4789-92DB-1959DFAA22F9Q34716360-7901D95E-2852-4986-B7F5-18C35DEDE60BQ37194095-DDFB6A6E-4A8C-45D3-ABC5-119E29DC083DQ37608110-BBE03C80-D903-4B09-B39F-D814774BFAFDQ37789032-41DAA98E-3089-4C2C-8524-C63E00DD4A57Q37829737-D65E525A-A838-4CBF-A698-0E698CAAF26BQ37887077-5BF1D974-6535-45A0-8C86-328E2E23B497Q37967179-8A681AFB-D8FA-4148-858E-C4793434833FQ38891772-165C8FC6-1A8B-4744-B95E-525CF0A3DB83Q39174984-85E5B892-B144-4485-BEC4-E4B4D5019D41Q41484905-5C13A052-1F58-487A-83E4-0F974ACA0561Q46954459-3BCE19DD-B43E-4975-806A-607B782C2A66Q47099886-A2EB4D30-1883-4208-84F0-8AF332B7E1E8Q47135878-3FDA3E54-3DEB-4631-A136-A536C9A3A232Q47277840-C5E2A415-04C3-4040-B4B0-A8A84ABCA678Q50131798-49918D08-BDD6-4D5E-825C-AEDD7C76EA2CQ52687472-7351011E-759B-407C-A560-75D9D92ED738Q53719845-0BD8AECC-2557-41F5-BF06-BCEC034C0C12Q54940561-A0D95F89-9EB0-4978-8618-DD38266B9891Q55391793-C65A6EF8-7F9F-4F58-BD72-22BB2D7BEF65
P2860
Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Isolation and characterization ...... heavy-chain antibody fragment.
@ast
Isolation and characterization ...... heavy-chain antibody fragment.
@en
type
label
Isolation and characterization ...... heavy-chain antibody fragment.
@ast
Isolation and characterization ...... heavy-chain antibody fragment.
@en
prefLabel
Isolation and characterization ...... heavy-chain antibody fragment.
@ast
Isolation and characterization ...... heavy-chain antibody fragment.
@en
P2093
P356
P1433
P1476
Isolation and characterization ...... heavy-chain antibody fragment.
@en
P2093
Dan L Crimmins
Jack H Ladenson
Ruth C Ladenson
Yvonne Landt
P304
P356
10.1021/AC058044J
P407
P577
2006-07-01T00:00:00Z